Welcome to Shaping Tomorrow

Global Scans · Diabetes · Weekly Summary


  • [New] Approximately 537 million adults were living with diabetes in 2021, a figure expected to rise to 643 million by 2030, creating a massive and sustained demand for effective treatments. Market Data Forecast
  • [New] Up to 400 milligrams of caffeine a day, roughly three to five cups of regular black coffee, is generally safe and may even be linked to lower risks of heart disease, stroke, heart failure, and Type 2 diabetes. ScienceDaily
  • [New] Structured lifestyle changes-moderate weight loss, regular physical activity, and dietary improvements-can significantly reduce the risk of developing type 2 diabetes in people with prediabetes. Local Health Alert
  • [New] A large study published in The BMJ found that eating three servings of French fries per week was associated with a 20% higher risk of developing type 2 diabetes. ScienceDaily
  • [New] Another $653 million in federal funding will expand public coverage to include free medications for diabetes and enhanced coverage for menopausal hormone therapy. BC Gov News
  • [New] Obesity and diabetes, which are estimated to affect roughly 13 and 9% of adults worldwide, respectively, are preventable chronic diseases for which poor nutrition quality is a significant risk factor. Frontiers
  • The new Dexcom Stelo Glucose Biosensor System, which will be available by summer, is intended for people 18 years and older who have type 2 diabetes but do not take insulin. www.PhysiciansWeekly.com
  • A range of major therapeutic areas - including diabetes, cardiovascular disease, immunology, oncology, and pain management - will see widely prescribed drugs lose patent protection in 2026. Drug Discovery News Magazine
  • FDA approves Ozempic for a new indication: reducing the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease. GoalBMI Wellness
  • FDA approves Rybelsus, the first oral semaglutide tablet for type 2 diabetes management - proving that the GLP-1 mechanism could be effective in pill form and setting up the later oral Wegovy development. GoalBMI Wellness
  • Red blood cells at high elevations absorb large amounts of glucose, explaining the lower diabetes risk in mountain-dwelling populations. Yahoo News
  • The Trump administration has proposed steep cuts of $5.78 billion to the National Institutes of Health for 2027, which could make it difficult for researchers and scientists to get funding, start new projects, and conduct long-term research to advance the field of diabetes care. diaTribe
  • Approximately 589 million adults (20-79 years) were living with diabetes in 2024, with the figure projected to reach 853 million by 2050. MarkNtel Advisors
  • Enrollees are not eligible if they already receive GLP-1 medications through their Medicare Part D drug plan or have type 2 diabetes, moderate to severe sleep apnea or fatty liver disease (which might make them eligible for coverage through Part D). KCRA
  • The inclusion of people with prediabetes represents an effort to prevent diabetes in the Medicare population, which will ultimately reduce healthcare costs nationally. CNBC
  • People who ate high amounts of animal protein - and, as a result, also consumed a high amount of methionine and other essential amino acids - were more likely to be obese and had double the risk of type 2 diabetes than individuals who ate little to no animal protein. Refractor
  • Researchers are taking a closer look at how different types of dietary fat may influence the risk of type 2 diabetes, a disease that affects millions of people worldwide and is linked to serious health complications and premature death. ScienceDaily
  • By managing weight, people can lower their risk of developing diabetes, heart disease, liver disease and cancer. Wbur
  • More than 640 million adults are projected to live with diabetes globally by 2030, increasing the need for routine wound-care solutions. Persistence Market Research
  • Under the GLP-1 Bridge Program, Medicare will cover Wegovy specifically for weight loss - not just for diabetes management. Pound of Cure Weight Loss
  • In the PAD Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) program, 30% of people aged 50-69 years with a history of cigarette smoking or diabetes, or aged > = 70 years regardless of risk factors, had PAD (223). PubMed Central (PMC)

Last updated: 16 August 2026



Please stand by...

The magic is happening, but it might take a couple of minutes.

Login